The drug targets a specific mutation that applies to only 2% of ALS patients. A new drug may slow progression of -- and even reverse -- symptoms of a rare form of amyotrophic lateral sclerosis, or ALS ...

Historically, people with amyotrophic lateral sclerosis (ALS) experience a relentless decline in neurological function that eventually robs them of the ability to move, speak, eat or breathe. Now, ...

Pharma's end-of-year dealmaking flurry is not showing signs of slowing, as, now, two Japanese drugmakers have joined the action with a multibillion-dollar asset transfer agreement. Monday, Shionogi ...

Years ago, when venture capitalist Jon Medved took an interest in backing various health tech startups, he had no idea that one day, he would need them to improve his own quality of life. Israel’s ...

AUSTIN (KXAN) — “It felt like I got wings and I was able to fly because ALS takes so much away from you. And Neuralink gave something back to me,” said Jake Schneider about the transformative ...

Editor’s note: Since 2021, Matt Rocheleau has served as an editor on data and investigative projects for the Times Union and Hearst Connecticut Media Group. In that time, he has worked on ...

Prefoldin 5 stabilises neuronal microtubules and suppresses Tau-mediated neurotoxicity, offering a potential therapeutic ...